Bruker products received FDA-approved updates.
1 report, 1 independent
Updated Jun 27
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Bruker products received FDA-approved updates.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- Inventiva seeks FDA approval for lanifibranor in the U.S. market.
- Amy Brenner hopes that a favorable FDA ruling will allow for more peptide products, noting her offices are in Kenwood and Mason.
- Bruker is headquartered in Billerica, Massachusetts, and operates from its offices there.
- Takeda announced FDA approval of its drug MIMRYLO, a decision supported by VERIFY results.
- FDA is currently reviewing cell therapy products like Breyanzi®, seeking approval for CAR-T cell therapies, but noted insufficient information to establish a link.